Race Oncology (ASX:RAC) CEO Dr Daniel Tillett joins Sarah Hughan at the Stockhead’s What The Facts?! video interview series to discuss side effects of traditional chemotherapy and the importance of protecting heart health as patients go through cancer treatment. 

The damage to the heart is one of the most serious side effects of cancer treatment, as the heart has no ability to repair itself. Race is focused on developing its drug bistantrene to both treat the cancer and protect the heart.